Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer

Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer

US Patent 10660954 · Granted May 26, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods, kits, and compositions for enhancing cellular therapy2025
Compositions, methods and kits for eliciting an immune response2024
Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibit2024
Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibit2024
Tetanus toxoid and CCL3 improve DC vaccines2023
Methods, kits, and compositions for enhancing cellular therapy2023
CCR2+ hematopoietic stem cells mediate T cell activation in adoptive cell therap2022
CCR2+ hematopoietic stem cells mediate T cell activation in adoptive cell therap2022
Compositions, methods and kits for eliciting an immune response2022
Compositions, methods and kits for eliciting an immune response2022
Compositions, methods and kits for eliciting an immune response2022
Compositions, methods and kits for eliciting an immune response2022